Rheumatoid Arthritis Clinical Trials in Chicago

Showing 481-500 of 1,857 trials

Improve PAD PERformance With METformin

NCT03054519

The PERMET trial will determine whether metformin daily for six months improves six-minute walk performance in individuals with peripheral artery disease compared to placebo.

Peripheral Artery Disease

Northwestern University203 participantsStarted May 2017

Gainesville, Florida, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +2 more locations

RECRUITINGPHASE22.2 miles

Study of JK07 in Patients With Chronic Heart Failure

NCT06369298

This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart failure. There will be 2 cohorts in this study: Cohort 1: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) of ≤ 40%. Cohort 2: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) \> 40% and ≤ 65%.

Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction

Salubris Biotherapeutics Inc282 participantsStarted Mar 2024

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +59 more locations

Improve PAD PERformance With METformin

Study of JK07 in Patients With Chronic Heart Failure

Rheumatoid Arthritis Trials in Other Cities

The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Quality Improvement and Practice Based Research in Neurology Using the EMR

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Actis Total Hip System 2 Year Follow-up

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

The ReTAVI Prospective Observational Registry

Oral Contraceptive Pill (OCP) Pharmacogenomics

Other Conditions in Chicago